LSD1 silencing inhibits the proliferation, migration, invasion, and epithelial-to-mesenchymal transition of hypopharyngeal cancer cells by inducing autophagy and pyroptosis

被引:4
|
作者
Wang, Hao [1 ]
Liu, Fang [2 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Otorhinolaryngol, Luwan Branch,Sch Med, Shanghai, Peoples R China
[2] Shanghai Ruijin Rehabil Hosp, Dept Otolaryngol, Shanghai, Peoples R China
[3] Shanghai Ruijin Rehabil Hosp, Dept Otolaryngol, 1100 Quxi Rd, Shanghai 200020, Peoples R China
来源
CHINESE JOURNAL OF PHYSIOLOGY | 2023年 / 66卷 / 03期
关键词
Autophagy; epithelial-to-mesenchymal transition; hypopharyngeal cancer; invasion; lysine-specific demethylase 1; pyroptosis; HEAD; PROGRESSION; EXPRESSION; MECHANISM; PROMOTES; TWIST;
D O I
10.4103/cjop.CJOP-D-22-00137
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Hypopharyngeal cancer is a subtype of the head and neck malignancies. We aimed to explore the role of lysine-specific demethylase 1 (LSD1/KDM1A) in the progression of hypopharyngeal cancer and to identify the potential mechanisms. First, LSD1 expression in head and neck squamous cell carcinoma (HNSCC) tissues and the correlation between LSD1 and the stage of HNSC were analyzed by the University of ALabama at Birmingham CANcer data analysis Portal (UALCAN). Following LSD1 silencing, proliferation of pharyngeal cancer cell line FaDu cells was evaluated by cell counting kit-8 and colony formation assays. Wounding healing and transwell assays were used to measure the capacities of migration and invasion. In addition, expression of proteins related to epithelial-to-mesenchymal transition (EMT), autophagy, and pyroptosis was tested by Western blot analysis or immunofluorescence. After treatment with autophagy inhibitor 3-methyladenine (3-MA) or NLR family pyrin domain containing 3 (NLRP3) inhibitor MCC950, the malignant biological properties were measured again. High LSD1 expression was observed in HNSC tissues, which was correlated with stage. LSD1 knockdown significantly suppressed the proliferation, migration, invasion, and EMT of hypopharyngeal cancer cells. Moreover, autophagy and pyroptosis were induced by LSD1 depletion, observed by the enhanced fluorescence intensity of LC3, gasdermin-D (GSDMD)-N, and apoptosis-associated speck-like protein containing a CARD (ASC), accompanied by upregulated expression of LC3II/LC3I, Beclin-1, NLRP3, cleaved-caspase 1, ASC, interleukin (IL)-1 beta, and IL-18 and downregulated expression of p62. Importantly, 3-MA or MCC950 addition obviously reversed the inhibitory effects of LSD1 silencing on the proliferation, migration, invasion, and EMT of hypopharyngeal cancer cells. To sum up, LSD1 silencing could restrain the progression of hypopharyngeal cancer cells by inducing autophagy and pyroptosis.
引用
收藏
页码:162 / 170
页数:9
相关论文
共 50 条
  • [31] Knockdown of ER-α36 expression inhibits glioma proliferation, invasion and epithelial-to-mesenchymal transition
    Zhao, Bowen
    Ye, Xiang
    Yang, Yuanyuan
    Wang, Yuxing
    Wang, Ru
    Pan, Xiaohua
    Wang, Molin
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2022, 305 (02): : 321 - 332
  • [32] Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition
    Ying, Liang
    Chen, Qi
    Wang, Yawei
    Zhou, Zhihua
    Huang, Yiran
    Qiu, Feng
    MOLECULAR BIOSYSTEMS, 2012, 8 (09) : 2289 - 2294
  • [33] Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells
    Ling, Yuwei
    Cao, Qi
    Liu, Yihan
    Zhao, Jing
    Zhao, Ye
    Li, Kaifu
    Chen, Zhiqiang
    Du, Xiaoyan
    Huo, Xueyun
    Kang, Hua
    Chen, Zhenwen
    BREAST CANCER, 2021, 28 (02) : 368 - 378
  • [34] PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells
    Li, Weiping
    Dong, Yongchao
    Zhang, Bin
    Kang, Yindong
    Yang, Xukai
    Wang, He
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 81 : 1 - 6
  • [35] Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells
    Yuwei Ling
    Qi Cao
    Yihan Liu
    Jing Zhao
    Ye Zhao
    Kaifu Li
    Zhiqiang Chen
    Xiaoyan Du
    Xueyun Huo
    Hua Kang
    Zhenwen Chen
    Breast Cancer, 2021, 28 : 368 - 378
  • [36] Capecitabine inhibits epithelial-to-mesenchymal transition and proliferation of colorectal cancer cells by mediating the RANK/RANKL pathway
    Shao, Minghai
    Jiang, Caiping
    Yu, Changhui
    Jia, Haijian
    Wang, Yanli
    Mao, Xinli
    ONCOLOGY LETTERS, 2022, 23 (03)
  • [37] Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells
    Chen, Wei
    Zhao, Kai
    Miao, Chenkui
    Xu, Aiming
    Zhang, Jianzhong
    Zhu, Jundong
    Su, Shifeng
    Wang, Zengjun
    ONCOTARGETS AND THERAPY, 2017, 10 : 1503 - 1512
  • [38] Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition
    Sanookpan, Kittipong
    Nonpanya, Nongyao
    Sritularak, Boonchoo
    Chanvorachote, Pithi
    MOLECULES, 2021, 26 (03):
  • [39] TSPAN7 promotes the migration and proliferation of lung cancer cells via epithelial-to-mesenchymal transition
    Wang, Xianguo
    Lin, Min
    Zhao, Jinping
    Zhu, Shaoping
    Xu, Ming
    Zhou, Xuefeng
    ONCOTARGETS AND THERAPY, 2018, 11 : 8815 - 8822
  • [40] Interleukin-23 promotes the migration and invasion of gastric cancer cells by inducing epithelial-to-mesenchymal transition via the STAT3 pathway
    Xu, Xianhui
    Yang, Changdong
    Chen, Jun
    Liu, Junyan
    Li, Ping'ang
    Shi, Yan
    Yu, Peiwu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 499 (02) : 273 - 278